Evidence map›Paper›PMID 31040502›Full record

ReviewMissouri medicine

The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?

Venkat N Subramaniam, Arthur R Menezes, Alban DeSchutter, Carl J Lavie

Open access · greenAbstract readReview
In one paragraph

Review in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Parasympathetic decreases immediately following self-reported cannabis smoking among adults living with cannabis use disorder.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2025
    Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Associations between Cannabis Consumption Methods and Cannabis Risk Perception.International journal of environmental research and public health · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Venkat N SubramaniamVenkat N. Subramaniam, MD, MS, was previously a medical student, and Arthur R. Menezes, MD, and Alban DeSchutter, MD, were previously cardiovascular fellows at Ochsner, and Carl J. Lavie, MD, currently works in the Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana. Dr. Subramaniam is currently affiliated with the Banner University Medical Center, Phoenix, Arizona.
Arthur R MenezesVenkat N. Subramaniam, MD, MS, was previously a medical student, and Arthur R. Menezes, MD, and Alban DeSchutter, MD, were previously cardiovascular fellows at Ochsner, and Carl J. Lavie, MD, currently works in the Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana. Dr. Subramaniam is currently affiliated with the Banner University Medical Center, Phoenix, Arizona.
Alban DeSchutterVenkat N. Subramaniam, MD, MS, was previously a medical student, and Arthur R. Menezes, MD, and Alban DeSchutter, MD, were previously cardiovascular fellows at Ochsner, and Carl J. Lavie, MD, currently works in the Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana. Dr. Subramaniam is currently affiliated with the Banner University Medical Center, Phoenix, Arizona.
Carl J LavieVenkat N. Subramaniam, MD, MS, was previously a medical student, and Arthur R. Menezes, MD, and Alban DeSchutter, MD, were previously cardiovascular fellows at Ochsner, and Carl J. Lavie, MD, currently works in the Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana. Dr. Subramaniam is currently affiliated with the Banner University Medical Center, Phoenix, Arizona.
Ochsner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marijuana is the most commonly abused illicit drug in the United States (US) and much of the Westernized World with a steadily increasing prevalence in usage and abuse over the past decade, especially among adolescents. Much of the available data on 9-tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana, relates to its neurological effects and anti-emetic properties, with very little on the cardiovascular (CV) effects of THC. Available literature shows that THC has three major effects on the CV and the peripheral vasculature in the form of "cannabis arteritis," cannabis-induced vasospasms, and platelet aggregation, with an unknown verdict on the relationship between marijuana use and atherosclerosis progression. This manuscript reviews these effects and possible mechanisms of action. Moreover, limitations on current views of marijuana and indirect causes of CV toxicity will be investigated, such as concurrent drug use, lifestyle, and mental health. The effects of marijuana on the CV system are extremely worrisome and likely need more attention due to the growing legalization of cannabis for medicinal and recreational use across the US. As a result, awareness among health care professionals about potential side effects and toxicities associated with acute and chronic exposure of cannabis will increase in importance.

Indexed as

CannabisDrug-Related Side Effects and Adverse ReactionsMarijuana AbuseAdolescentCannabinoidsCardiovascular SystemHumansMarijuana SmokingUnited StatesCannabinoids

Identifiers

PMID31040502
PMCPMC6461323
OpenAlexW2980887588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.